In yesterday’s Wall Street session, Teladoc Health Inc (NYSE:TDOC) shares traded at $10.95, down -4.78% from the previous session.
TDOC stock price is now 16.10% away from the 50-day moving average and 1.66% away from the 200-day moving average. The market capitalization of the company currently stands at $1.89B.
With the price target of $14, Goldman recently initiated with Buy rating for Teladoc Health Inc (NYSE: TDOC). On September 17, 2024, Jefferies reiterated its ‘Hold’ rating on the stock by increasing its target price from $8 to quote $10, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
In other news, Nueno Carlos, President, International sold 2,890 shares of the company’s stock on Dec 03 ’24. The stock was sold for $32,455 at an average price of $11.23. Upon completion of the transaction, the President, International now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 02 ’24, President, International Nueno Carlos sold 2,389 shares of the business’s stock. A total of $28,494 was realized by selling the stock at an average price of $11.93. This leaves the insider owning 2,890 shares of the company worth $31645.5. A total of 2.12% of the company’s stock is owned by insiders.
During the past 12 months, Teladoc Health Inc has had a low of $6.76 and a high of $22.54. As of last week, the company has a debt-to-equity ratio of 1.05, a current ratio of 1.69, and a quick ratio of 1.65. The fifty day moving average price for TDOC is $9.386 and a two-hundred day moving average price translates $10.8212 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for 2024-09-30. The net profit margin was -37.91% and return on equity was -51.65% for TDOC. The company reported revenue of $640.51 million for the quarter, compared to $660.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.99 percent.
